Amy Emerson is the founder of Lykos Therapeutics. Lykos Therapeutics has raised $100M in total funding. Latest round: Series A.
Amy Emerson is the CEO of Lykos Therapeutics, a company formerly known as MAPS PBC. Lykos Therapeutics focuses on the clinical development of MDMA-assisted therapy for post-traumatic stress disorder (PTSD). The company recently secured $100 million in Series A funding and submitted its new drug application to the FDA.
Full founder directory · Investor directory · Company funding database · Fundraising library